Raynaud Phenomenon clinical trials

Explore recruiting raynaud phenomenon clinical trials.

Recruiting raynaud phenomenon studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Raynaud Phenomenon trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase II/III double-blind randomized placebo-controlled trial assessing the preventive effect of Clopidogrel on the systemic sclerosis development risk in subjects with specific dysimmunity and Raynaud phenomenon - PSSIT

France

Phase II and Phase III (Integrated) EU CTIS Study details

A Phase II, randomised, placebo-controlled, double-blind, parallel-group, efficacy and safety study of at least 48 weeks of oral BI 685509 treatment in adults with progressive systemic sclerosis

Spain, Denmark, France, Austria, Belgium, Netherlands +11 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Raynaud Phenomenon trials by city

Raynaud Phenomenon in Toronto Raynaud Phenomenon in Vancouver Raynaud Phenomenon in Montreal Raynaud Phenomenon in Calgary Raynaud Phenomenon in Edmonton Raynaud Phenomenon in Ottawa Raynaud Phenomenon in Winnipeg Raynaud Phenomenon in Quebec City Raynaud Phenomenon in Hamilton Raynaud Phenomenon in Kitchener Raynaud Phenomenon in London Raynaud Phenomenon in Halifax Raynaud Phenomenon in New York Raynaud Phenomenon in Los Angeles Raynaud Phenomenon in Chicago Raynaud Phenomenon in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease